Comparative antioxidant effects of β-adrenoceptor blockers, calcium antagonists and U-74500A against iron-dependent lipid peroxidation in murine ventricular microsomal membranes

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue 9, 1996, Pages 559-567

  Reddy, Doodipala Samba ^a   Singh, M ^a   Chopra, K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

blockers; calcium antagonists; ischemia; ischemia reperfusion; lipid peroxidation; oxygen free radicals; propranolol; ventricular membranes; verapamil

Indexed keywords

21 [4 [5,6 BIS(DIETHYLAMINO) 2 PYRIDYL] 1 PIPERAZINYL] 16ALPHA METHYLPREGNA 1,4,9(11) TRIENE 3,20 DIONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FREE RADICAL; GALLOPAMIL; IRON; METOPROLOL; NIFEDIPINE; PROPRANOLOL; TIMOLOL; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; HEART PROTECTION; HEART VENTRICLE; ISCHEMIA; LIPID PEROXIDATION; MALE; MICROSOME MEMBRANE; MOUSE; NONHUMAN; REPERFUSION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIOXIDANTS; CALCIUM CHANNEL BLOCKERS; CULTURE TECHNIQUES; FEMALE; HEART VENTRICLES; IRON; LIPID PEROXIDATION; MALE; MICE; MICROSOMES; PREGNATRIENES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0030457141     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Reddy, D.S., Chopra, K., Singh, M., Ganguly, N.K. Anti-free radical and cardioprotective drugs in ischemic myocardial injury. Drugs Today/Med Actual 1995, 31: 335-49.
2. Downey, J.M. Free radicals and other involvement during long-term myocardial ischemia and reperfusion. Annu Rev Physiol 1990, 52: 487-504.
3. Kukreja, R.C., Hess, M.L. The oxygen free radical system: From equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 1992, 29:641-55.
4. Braughler, J.M., Hall, E.D. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 1989, 6: 289-301.
5. Braughler, J.M., Hall, E.D. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med 1989, 6: 303-13.
6. Yellon, D.M., Downey, J.M. Current research views on myocardial reperfusion and reperfusion injury. Cardioscience 1990, 1: 89-98.
7. McCord, J.M. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med 1985, 312: 159-63.
8. McCord, J.M. Oxygen-derived radicals: A link between reperfusion injury and inflammation. Fed Proc 1987, 46: 2402-6.
9. Rao, P.S., Cohen, M.D.V., Muller, H.S. Production of free radicals and lipid peroxides in early experimental myocardial ischemia. J Mol Cell Cardiol 1983, 15: 713-6.
10. Meerson, F.Z., Kagan, V.E., Kozlov, Y.P., Belkina, L.M., Arkhipenki, Y.U. The role of lipid peroxidation in pathogenes is of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 1982, 77: 465-85.
11. Rao, P.S., Liu, X., Das, D.K., Weinstein, G.S., Tyras, D.H. Protection of ischemic heart from reperfusion injury by myoinositol hexaphosphate, a natural antioxidant. Ann Thorac Surg 1991, 52: 908-12.
12. Azhar, J., Santos, M.T., Valles, J., Sala, J. Serum malondialdehyde-like material (MDA-LM) in acute myocardial infarction. J Clin Pathol 1983, 36: 712-5.
13. Dousset, J-C., Trouilh, M., Foglefti, M-J. Plasma malondialdehyde levels during myocardial infarction. Clin Chim Acta 1983, 129: 712-5.
14. Leoper, J., Goy, J., Rozansztan, L., Bedu, O., Moisson, P. Lipid peroxidation and protective enzymes during myocardial infarction. Clin Chim Acta 1991, 196: 119-26.
15. Halliwell, B., Gutteridge, J.M.C. In: Free Radicals in Biology and Medicine, 2nd ed. Clarendon Press: Oxford 1989, 442-4.
16. Braughler, J.M., Pregenzer, J.F., Chase, R.L., Duncan, L.A., Jacobsen, E.J., McCall, J.M. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987, 262: 10438-40.
17. Fisher, M., Levine, P.H., Cohen, R.A. A 21-aminosteroid reduces hydrogen peroxide generation and chemiluminescence of stimulated human leukocytes. Stroke 1990, 21: 1435-8.
18. Levitt, M.A., Sievers, R.E., Wolfe, C.L. Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid, a novel 21-aminosteroid. Clin Res 1991, 39: Abst 265.
19. Ambrosio, G., Becker, L.C., Hutchens, G.M., Weisman, H.F., Weisfeldt, M.I. Reduction in experimental infarct size by recombinant human superoxide dismutase: Insight into the pathophysiology of reperfusion injury. Circulation 1985, 74: 895-8.
20. Reddy, D.S., Singh, M. Captopril and lisinopril inhibit iron-dependent lipid peroxidation in murine ventricular membranes. Pharmacol Commun 1996, 7: 199-208
21. Mak, I.T., Weglick, W.B. Protection by β-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 1988, 63: 262-6.
22. Janero, D.R., López, R., Pittman, J., Burghardt, B. Propranolol as xanthine oxidase inhibitor: Implications for antioxidant activity. Life Sci 1989, 44: 1579-88.
23. Mak, I.T., Arroyo, C.M., Weglick, W.B. Inhibition of sarcolemmal carbon centered free radical formation by propranolol. Circ Res 65: 1151-6.
24. Aruoma, O.I., Smith, C., Cecchini, R., Evans, P.J., Halliwell, B. Free radical scavenging and inhibition of lipid peroxidation by β-blockers and by agents that interfere with calcium metabolism. Biochem Pharmacol 1991, 42: 735-43.
25. Yue, T.L., Liu, T., Feuerstein, G.Z. Carvedilol, a new β-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits oxygen-radical mediated lipid peroxidation in swine ventricular membranes. Pharmacol Commun 1992, 1: 27-35.
26. Yue, T.L., Cheng, H-Y., Lysko, P.G. et al. Carvedilol, a new vasodilator und β-adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992, 263: 92-8.
27. Weglick, W.B., Mak, I.T., Simic, M.G. Mechanism of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 1990, 22: 1199-208.
28. Cantoni, O., Sestil, P., Cattabeni, F. et al. Calcium chelator quin 2 prevents hydrogen-peroxide-induced DNA breakage and cytotoxicity. Eur J Biochem 1989, 182: 209-12.
29. 2+ chelators prevent DNA damage and protect hepatoma ICIC7 cells from quinone-induced cell killing. Free Radic Res Commun 1990, 8: 347-54.
30. 2+ antagonists. J Mol Cell Cardiol 1988, 20: 811-23.
31. Kloner, R.A., Przyklenk, K. Progress in cardioprotection: The role of calcium antagonists. Am J Cardiol 1990, 66: 2-9H.
32. Przyklenk, K., Kloner, R.A. Effect of verapamil on postischemic "stunned myocardium": Importance of liming of treatment. J Am Coll Cardiol 1988, 11: 614-23.
33. Przyklenk, K., Ghafari, G.B., Eitzman, D., Kloner, R.A. Nifedipine administered after reperfusion abates systolic contractile dysfunction of post-ischemic stunned myocardium. J Am Coll Cardiol 1989, 13: 1176-83.
34. Janero, D.R., Burghardt, B., López, R. Protection of cardiac membrane phospholipids against oxidative injury by calcium antagonists. Biochem Pharmacol 1988, 37: 4197-203.
35. Janero, D.R., Burghardt, B. Antiperoxidant effects of dihydropyridine calcium antagonists. Biochem Pharmacol 1989, 38: 4344-8.
36. Reddy, D.S., Singh, M. Antiperoxidative effects of platelet activating factor antagonists against iron-dependent lipid peroxidation in murine ventricular membrane. Meth Find Exp Clin Pharmacol 1995, 17: 383-90.
37. Lowry, O.H., Rosebrough, N.J., Far, A.L., Randall, R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193: 265-75.
38. Chopra, K., Singh, M., Gupta, S., Ganguly, N.K. Involvement of oxygen free radicals in the action of BN 52021 (PAF antagonist) to limit myocardial infarct size. Meth Find Exp Clin Pharmacol 1993, 15: 437-45.
39. Chopra, K., Singh, M., Kaul, N., Ganguly, N.K. Oxygen free radicals and protective effect of captopril on myocardial infarct size. Arch Int Pharmacodyn 1993, 322: 55-65.
40. Krammer, J.H., Mak, I.T., Weglick, W.B. Differential sensitivity of canine cardiac sarcolemmal and microsomal 2 enzymes to inhibition by free radical-induced lipid peroxidation. Circ Res 1984, 55: 120-4.
41. Halliwell, B. How to characterize a biological antioxidant. Free Radic Res Commun 1990, 9: 1-32.
42. Gutteridge, J.M.C. Aspects to consider when detecting and measuring lipid peroxidation. Free Radic Res Commun 1986, 1: 173-84.
43. Mak, I.T., Weglick, W.B. Comparative antioxidant activities of propranolol, nifedipine, verapamil and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 1992, 66: 1999-2052.
44. Ceconi, C., Cargoni, A., Pasini, E., Candorelli, E., Curello, S., Ferrari, R. Evaluation of phospholipid peroxidation and malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol 1991, 260: H1057-61.
45. Chester, D.W., Herbetee, L.G., Mason, R.P., Joslyn, A.F., Triggle, D.J., Koppel, D.E. Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multilayers. Biophys J 1987, 52: 1021-30.